Pharmaceutically used polymers: Principles, structures, and applications of pharmaceutical delivery systems

Handbook of Experimental Pharmacology

Volumn 197, Issue , 2010, Pages 221-250

  Khandare, Jayant ^b   Haag, Rainer ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

Biomaterials; Controlled release system; Novel drug delivery systems; Polymer therapeutics; Polymers

Indexed keywords

ALGAROBA; ALGINIC ACID; BIOMATERIAL; CARBOMER; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; CIPROFLOXACIN; DENDRIMER; ETHYL CELLULOSE; EUDRAGIT; EXCIPIENT; FLUOXETINE; GANTREZ; GANTREZ COPOLYMER; GUAR GUM; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; METHYLCELLULOSE; PANACRYL; PAROXETINE; POLYACRYLIC ACID; POLYANHYDRIDE; POLYCAPROLACTONE; POLYETHYLENE; POLYGLACTIN; POLYLYSINE; POLYMER; POLYURETHAN; POLYVINYL ALCOHOL; PROZAC WEEKLY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VICRYL RAPID; DRUG; DRUG CARRIER;

CONTROLLED DRUG RELEASE; DELAYED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; ENTERIC COATED TABLET; HUMAN; NONHUMAN; OSMOTIC PUMP; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; REVIEW; SINGLE DRUG DOSE; STRUCTURE ANALYSIS; TABLET MANUFACTURE; CHEMISTRY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; DELAYED-ACTION PREPARATIONS; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 77953242324     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-00477-3_8     Document Type: Review

References (82)

1. Abuchowski A, Van Es T, Palczuk NS, Davis FF (1997) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252:3578-3581
2. Alakhov V, Pietrzynski G, Patel K, Kabanov A, Bromberg L, Hatton TA (2004) Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. J Pharm Pharmacol 56:1233-1241
3. Arora S, Ali A, Ahuja A, Baboota S, Qureshi J (2006) Pulsatile drug delivery systems: An approach for controlled drug delivery. Ind J Pharm Sci 68:295-300
4. Bergsma EJ, Rozema FR, Bos RR, de Bruijn WC (1993) Foreign body reactions to resorbable poly (L-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures. J Oral Maxillofac Surg 51:666-670
5. Betancourt T, Brown B, Brannon-Peppas L (2007) Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine 2:219-232
6. Boldhane S (2008) Development and evaluation of oral platform drug delivery technology. In: Shivaji University, vol Ph.D. Thesis pp 12-13
7. Brazel CS, Peppas NA (2000) Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 49:47-58
8. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymerbrain tumor treatment group. Lancet 345:1008-1012
9. Bromberg L (2008) Polymeric micelles in oral chemotherapy. J Control Release 128:99-112
10. Chasin M, Domb A, Ron E, Mathiowitz E, Langer R, Leong K, Laurencin C, Brem H, Grossman S (1990) Polyanhydrides as drug delivery systems. In: Chasin M, Langer R (eds) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, pp 43-70
11. Choi BY, Park HJ, Hwang SJ, Park JB (2002) Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents. Int J Pharm 239:81-91
12. Chourasia MK, Jain SK (2003) Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Sci 6:33-66
13. Colombo P, Santi P, Bettini R, Prazel CS, Peppas NA (2000) Mechanism-based classification of controlled release devices. In: Wise DL (ed) Handbook of pharmaceutical controlled release technology. CRC Press, New York, p 493
14. David A, Kopeckova P, Kopecek J, Rubinstein A (2002) The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells. Pharm Res 19:1114-1122
15. de Leeuw BJ, Lueben HL, Pérard D, Verhoef AC, de Boer AG, Junginger HE (1995) The effect of mucoadhesive poly(acrylates) polycarbophil and carbomer on zinc and calcium dependent proteases. Proc Int Symp Control Rel Bioact Mater 22:528-529
16. Degussa (2001) http://www.degussa-history.com/geschichte/en/inventions/ eudragit/in:
17. Dittigen M, Fricke S, Timpe C, Gercke H, Eichardt A (2000) Method of making a perorally administered solid drug with controlled effective ingredient delivery. US Patent No 6117450, USA
18. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2:347-360
19. Duncan R, Seymour L (2007) Hiroshi Maeda-defining the pathway to targeted cancer therapy. J Drug Target 15:456
20. FDA (2004) http://www.fda.gov/medwatch/SAFETY/2004/jul-PI/CiproXR-PI.pdf
21. FDA (2006a) http://www.fda.gov/cder/foi/label/2006/018936s076lbl.pdf
22. FDA (2006b) http://www.fda.gov/medwatch/safety/2006/Paxil%20CR-PI.pdf
23. FDA (2008) http://www.fda.gov/cber/rules/amendcgmpfinal.htm
24. FDA (2008a) http://www.fda.gov/cder/dmpq
25. Field JR, Stanley RM (2004) Suture characteristics following incubation in synovial fluid or phosphate buffered saline. Injury 35:243-248
26. Ford JE (1994) Fundamental aspects of drug release form hydrophilic matrix tablets. In: Proc Colorcon Controlled Release Symposium, pp 1-26
27. Gazzaniga A, Palugan L, Foppoli A, Sangalli ME (2008) Oral pulsatile delivery systems based on swellable hydrophilic polymers. Eur J Pharm Biopharm 68:11-18
28. Guyot M, Fawaz F (2000) Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm 204:171-182
29. Haag R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem Int Ed 45:1170-1179
30. Haag R, Sunder A, Stumbé JF (2000) An approach to glycerol dendrimers and pseudo-dendritic polyglycerols. J Am Chem Soc 122:2954-2955
31. Hamdan AM, Moseke C, Blanco L, Barralet JE, Lopez-Carbacos E, Gbureck U (2008) Strontium modified biocements with zero order release kinetics. Biomaterials 29:4691-4697
32. Haus E (2007) Chronobiology in the endocrine system. Adv Drug Deliv Rev 59:985-1014
33. Hebden JM, Wilson CG, Spiller RC, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC (1999) Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm Res 16:1087-1092
34. Jian-Hwa G (2003) Carbopol1 polymers for pharmaceutical drug delivery applications. Drug Del Tech 3:6
35. Khandare JJ, Minko T (2006) Polymer-drug conjugates: progress in polymeric prodrugs. Progress Polymer Sci 31:359-397
36. Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T (2006) Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug Chem 17:1464-1472
37. Kopecek J, Bazilova H (1973) Poly(N-(hydroxypropyl)-methacrylamide) radical polymerization and copolymerization. Eur Polym J 9:7-14
38. Langer R, Chasin M (1990) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, p 47
39. Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R (1990) Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J Biomed Mater Res 24:1463-1481
40. Lee WC, Chu IM (2008) Preparation and degradation behavior of polyanhydrides nanoparticles. J Biomed Mater Res B Appl Biomater 84:138-146
41. Lee CC, MacKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517-1526
42. Lee H, Lee K, Park TG (2008) Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem 19:1319-1325
43. Lehr CM, Bouwstra JA, Tukker JJ, Junginger HE (1990) Intestinal transit of bioadhesive microspheres in an in situ loop in the rat: a comparative study with copolymers and blends based on poly(acrylic acid). J Control Release 13:51-62
44. Lehr CM, Bouwstra JA, Bodde HE, Junginger HE (1992) A surface energy analysis of mucoadhesion: contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm Res 9:70-75
45. Lieberman HA, Lachman L, Schwartz JB (1990) Pharmaceutical dosage forms: tablets. Marcel Dekker, New York, pp 118-233
46. Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr (2005) Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem 48:5892-5899
47. Majoros IJ, Williams CR, Baker JR Jr (2008) Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem 8:1165-1179
48. McLeod AD, Friend DR, Tozer TN (1993) Synthesis and chemical stability of glucocorticoid- dextran esters: potential prodrugs for colon-specific delivery. Int J Pharm 92:105-114
49. Mehvar R, Dann RO, Hoganson DA (2000) Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. J Control Release 68:53-61
50. Middleton JC, Tipton AJ (1998) Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21:2335-2346
51. Minko T, Khandare JJ, Jayant S (2007) Polymeric Drugs. In: Matyjaszewski K, Gnanou Y, Leibler L (eds) Macromolecular engineering: from precise macromolecular synthesis to macroscopic material properties and application. Wiley-VCH, Weinheim, pp 2541-2595
52. Mura P, Maestrelli F, Cirri M, Gonzalez Rodriguez ML, Rabasco Alvarez AM (2003) Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. J Drug Target 11:365-371
53. Newcome GR, Moorefield CN, Keith JN, Baker GR, Escamilla GH (1994) Chemistry within a unimolecular micelle precursor: Boron superclusters by site- and depth-specific transformations of dendrimers. Angew Chem Int Ed 33:2413-2420
54. Papp I, Dernedde J, Enders S, Haag R (2008) Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behavior. Chem Commun 44:5851-5853
55. Park TG, Cohen S, Langer RS (1994) Controlled drug delivery using polymer/pluronic blends. US Patent No.5330768 USA
56. Pendri A, Martinez A, Xia J, Shorr RG, Greenwald RB (1995) Poly(ethylene glycol) fluorescent linkers. Bioconjug Chem 6:596-598
57. Perez-Marcos B, Gutierrez C, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A (1991) Usefulness of certain varieties of Carbopol in the formulation of hydrophilic furosemide matrices. Int J Pharm 67:113-121
58. Quadir MA, Radowski MR, Kratz F, Licha K, Hauff P, Haag R (2008) Dendritic multishell architectures for drug and dye transport. J Control Release: 132:289-294
59. Rihova B, Bilej M, Vetvicka V, Ulbrich K, Strohalm J, Kopecek J, Duncan R (1989) Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. Biomaterials 10:335-342
60. Ross AC, MacRae RJ, Walther M, Stevens HN (2000) Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol 52:903-909
61. Roy P, Shahiwala A (2009) Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release 134:74-80
62. Santus C, Baker (1995) Osmotic drug delivery: a review of the patent literature. J Control Release 35:1-21
63. Shishu GN, Aggarwal N (2007) Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. AAPS PharmSciTech 8:48
64. Shive MS, Anderson JM (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5-24
65. Smolensky MH, Peppas NA (2007) Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 59:828-851
66. Stiribara SE, Frey H, Haag R (2002) Dendritic polymers in biomedical applications: from potential to clinical use in diagnosis and therapy. Angew Chem Int Ed 41:1329-1334
67. Streubel A, Siepmann J, Bodmeier R (2002) Floating microparticles based on low density foam powder. Int J Pharm 241:279-292
68. Sunder A, Hanselmann R, Frey H, Mulhaupt R (1999) Controlled synthesis of hyperbranched polyglycerols by ring-opening multibranching polymerization. Macromolecules 32:4240-4246
69. Sunder A, Mülhaupt R, Haag R, Frey H (2000) Hyperbranched polyether polyols: a modular approach to complex polymer architectures. Adv Mater 12:235-239
70. Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H (2001) Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm 215:263-267
71. Takada K (1997) Controlled-release preparations. US Patent No 5,637,319, USA
72. Tiainen J, Veiranto M, Suokas E, Tormala P, Waris T, Ninkovic M, Ashammakhi N (2002) Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. J Craniofac Surg 13:427-433
73. Tomalia DA, Fréchet JM (2005) Introduction to dendrimers and dendritic polymers. Prog Polym Sci 30:294-324
74. Türk H, Haag R, Alban S (2004) Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug Chem 15:162-167
75. Türk H, Shukla A, Alves Rodrigues PC, Rehage H, Haag R (2007) Water-soluble dendritic core-shell-type architectures based on polyglycerol for solubilization of hydrophobic drugs. Chemistry 13:4187-4196
76. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Polymeric systems for controlled drug release. Chem Rev 99:3181-3198
77. Ulbrich K, Etrych T, Chytil P, Jelinkova M, Rihova B (2003) HPMA copolymers with pHcontrolled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. J Control Release 87:33-47
78. Venuganti VV, Perumal OP (2008) Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int J Pharm 361:230-238
79. Wang L, Kristensen J, Ruffner DE (1998) Delivery of antisense oligonucleotides using HPMA polymer: synthesis of thiol polymer and its conjugation to water-soluble molecules. Bioconjug Chem 9:749-757
80. Wang D, Kopeckova JP, Minko T, Nanayakkara V, Kopecek J (2000) Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. Biomacromolecules 1:313-319
81. Yang L, Eshraghi J, Fassihi R (1999) A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J Control Release 57:215-222
82. Zhou J, Wu J, Hafdi N, Behr J-P, Erbacher P, Peng L (2006) PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun 14:2362-2364